Voyager Life PLC Director/PDMR Shareholding (9586V)

TIDMVOY

RNS Number : 9586V

Voyager Life PLC

17 December 2021

17 December 2021

Voyager Life plc

("Voyager" or the "Company")

Directors' Dealings

Voyager, the health and wellness company supplying high-quality Cannabidiol (CBD), hemp seed oil and hemp-related products, announces that it was informed on 16 December 2021, Nick Tulloch, Chief Executive Officer, and Eric Boyle, Non-Executive Chairman, acquired respectively 537,776 and 519,112 ordinary shares in the Company at a price of 18 pence per share ("Ordinary Shares"). The Ordinary Shares were purchased from two of the Company's original shareholders and members of the concert party as set out in Voyager's admission document dated 28 June 2021.

Following these purchases, Nick Tulloch is beneficially interested in 1,321,776 Ordinary Shares, representing 14.3 per cent. of the Company's issued share capital and Eric Boyle is beneficially interested in 840,000 Ordinary Shares, representing 9.1 per cent. of the Company's issued share capital.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain. The Directors of the Company accept responsibility for the content of this announcement.

S 

Enquiries:

Voyager

Nick Tulloch - [e-mail] / 01738 505 130

http://voyagerlife.uk

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Ludovico Lazzaretti or Liam Murray [phone]

Notes to Editors:

About Voyager

Voyager was founded in 2020 and is based in Perth, Scotland. The Company's primary objective is the formulation and supply of high quality CBD and hemp seed oil products although it also produces several other complementary products, the majority of which are manufactured from the hemp plant. Its product categories include a pet range which has rapidly developed into one of the Company's best sellers.

In line with UK regulations, the Company makes no medicinal claims but guarantees to customers that its products are as described on their labels and on its website. Voyager's products do not contain any THC. Voyager focuses its resources on product formulations and retail and outsources its manufacturing to specialists. The Company's philosophy of plant-based health and wellness is embodied in its mission statement and hashtag of "Choose you". With an experienced team and a product line created in line with the UK's regulatory regime, Voyager aims to become the trusted brand in this increasingly popular health and wellness space.

Website and social media links:

https://voyagercbd.com/

https://www.instagram.com/voyagercbd/

https://twitter.com/voyagercbd

https://www.linkedin.com/company/voyager-cbd/

https://www.facebook.com/VoyagerCBD/

 
 1.    Details of PDMR / person closely associated with them ("PCA") 
 a)    Name                                              Nicholas Tulloch 
      ------------------------------------------------  -------------------------------------------------------------- 
 2.    Reason for the notification 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Position / status                                 CEO 
      ------------------------------------------------  -------------------------------------------------------------- 
 b)    Initial notification / amendment                  Initial notification 
      ------------------------------------------------  -------------------------------------------------------------- 
 3.    Details of the issuer, UK emission allowance market participant, auction platform or auctioneer 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                              Voyager Life plc 
      ------------------------------------------------  -------------------------------------------------------------- 
 b)    LEI                                               213800XIUQ3AHRZ6UF89 
      ------------------------------------------------  -------------------------------------------------------------- 
 2.    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument           Ordinary shares of 1 pence each 
      ------------------------------------------------  -------------------------------------------------------------- 
 b)    Nature of the transaction                         Acquisition 
      ------------------------------------------------  -------------------------------------------------------------- 
 c)    Price(s) and volume(s)                            Price(s)                        Volume(s) 
                                                        ------------------------------  ------------------------------ 
   18 pence                                                                              537,776 
  ------------------------------------------------------------------------------------  ------------------------------ 
 
 
 
 d)    Aggregated information Aggregated volume Price 
                                                           537,776 ordinary shares at a price of 18 pence per share 
      ------------------------------------------------  -------------------------------------------------------------- 
 e)    Date of the transaction                           16 December 2021 
      ------------------------------------------------  -------------------------------------------------------------- 
 f)    Place of the transaction                          Outside a trading venue 
      ------------------------------------------------  -------------------------------------------------------------- 
 
 
 1.    Details of PDMR / person closely associated with them ("PCA") 
 a)    Name                                              Eric Boyle 
      ------------------------------------------------  -------------------------------------------------------------- 
 2.    Reason for the notification 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Position / status                                 Chairman 
      ------------------------------------------------  -------------------------------------------------------------- 
 b)    Initial notification / amendment                  Initial notification 
      ------------------------------------------------  -------------------------------------------------------------- 
 3.    Details of the issuer, UK emission allowance market participant, auction platform or auctioneer 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                              Voyager Life plc 
      ------------------------------------------------  -------------------------------------------------------------- 
 b)    LEI                                               213800XIUQ3AHRZ6UF89 
      ------------------------------------------------  -------------------------------------------------------------- 
 2.    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument           Ordinary shares of 1 pence each 
      ------------------------------------------------  -------------------------------------------------------------- 
 b)    Nature of the transaction                         Acquisition 
      ------------------------------------------------  -------------------------------------------------------------- 
 c)    Price(s) and volume(s)                            Price(s)                        Volume(s) 
                                                        ------------------------------  ------------------------------ 
   18 pence                                                                              519,112 
  ------------------------------------------------------------------------------------  ------------------------------ 
 
 
 
 d)    Aggregated information Aggregated volume Price 
                                                           519,112 ordinary shares at a price of 18 pence per share 
      ------------------------------------------------  -------------------------------------------------------------- 
 e)    Date of the transaction                           16 December 2021 
      ------------------------------------------------  -------------------------------------------------------------- 
 f)    Place of the transaction                          Outside a trading venue 
      ------------------------------------------------  -------------------------------------------------------------- 
 

, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com. 

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXFFUFWMEFSEIE

(END) Dow Jones Newswires

December 17, 2021 02:00 ET (07:00 GMT)